Microbiome analysis in Lithuania: overview of the global and Lithuanian ecosystem, strengths, weaknesses, and recommendations

Problem

Chronic diseases including diabetes, cancer, and heart disease are the world’s leading causes of mortality and morbidity. They are responsible for 41 million deaths each year, or 74% of all deaths globally according to the World Health Organization. In response, the United Nations’ 2030 Sustainable Development Goals aim to reduce premature mortality from chronic diseases by one-third. These goals emphasize the importance of prevention, treatment, and mental health promotion in combating these issues.

The human microbiome is a growing research area in the prevention and treatment of chronic diseases and other illnesses such as COVID-19. The microbiome is made up of trillions of microorganisms, including bacteria, viruses, fungi, and archaea that reside in and on our bodies, and plays a vital role for our health by supporting the immune system and preventing disease.  The European Innovation Council recognizes gut microbiome analysis and therapy as significant innovations with the potential to address the global challenge of chronic diseases.

With the growing global emphasis on the microbiome and the rise of chronic diseases, it is essential to explore Lithuania’s potential within this field. In 2022, Lithuania’s expanding life sciences sector contributed 2.7% to the country’s GDP, with a goal of increasing this percentage to 5% by 2030. Microbiome research presents a significant opportunity to support this ambition by meeting the rising demand for innovative health solutions.

Further growth is supported by strategic initiatives such as the “New Generation Lithuania” plan, which focuses on investments in education, innovation, and personalized healthcare. This plan lays a solid foundation for breakthroughs in microbiome-related health technologies, contributing to improved public health outcomes and positioning Lithuania as an emerging leader in this field.

Goal

The goal of the project is to enhance Lithuania’s global competitiveness in the microbiome sector by identifying recommendations for promising scientific and industrial opportunities.

Participants

2024/25

Greta Šimeliūnaitė

2024/25

Ieva Juzumaitė